Survey SFAR: The use of OFA in 2020 in France
The evaluation of the actual diffusion in 2020, the use of OFA, used molecules and the used modalities. Click here to start the survey.
SARB recommendations for the anesthetic management of patients suspected of being infected or infected by the new coronavirus initially named 2019-nCoV
(last update: 3/04/ 2020 17:30)
(last update: 30/03/ 2020 14:00)
We would like you to consider participating in the BlueBerry study. This academic study, on the initiative of Pr Habré, University of Geneva, will analyze the safety profile of dexamethasone after tonsillectomy in children compared to placebo. We are currently submitting this study to our Ethics Committee, as well as to the Belgian authorities. In that, we can act as National Coordinator for this study. If you would like to participate in this study, please send us an email with your contact details as soon as possible before March 10th. We can then include your center in the submission. Please refer to the leaflet available here for further information.
Please send your mail to: françoise.firstname.lastname@example.org, who will act as National Coordinator.
Do not send an email to the Swiss center as they will not handle the submission in Belgium.
Coronavirus Safety Guidelines
In light of the recent outbreak of coronavirus (COVID-19), WFSA has uploaded a new resource outlining safety guidelines for anaesthesia and perioperative care providers. This resource will be updated if and when more information becomes available. Please find more information here.
Issue 1 – Fall 2019 is available here.
A prospective multi-centre international observational study of postoperative vasopressor use
Honor to Philippe Baele
Syndromes & rare diseases in Pediatrics: Anesthesia
Syndromes et maladies rares en anesthésie pédiatrique
Very important website in emergency situations when there is few time to go through the literature to find which could be the anesthetic implications of a syndrome or a rare condition presented by a pediatric patient.
Communication regarding the new measures to emphasize the existing limitations of Hydroxyetheyl starch-containing genomic drugs
Graag informeren wij u over het feit dat de opdruk op de Durogesic pleisters voor transdermaal gebruik is aangepast; de pleisters zullen een gekleurde rand bevatten. De pleisters met het nieuwe ontwerp zullen beschikbaar zijn op de markt vanaf eind november. Klik hier voor meer informatie.
On tient à vous signaler que l’impression figurant sur les dispositifs transdermiques Durogesic a été adaptée ; les patchs comporteront dorénavant un bord coloré.
Les nouveaux patchs adaptés seront disponibles sur le marché dès la fin novembre. Cliquez-ici.